The Net Margin of CRISPR Therapeutics AG (CRSP) is -981.54%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -981.54% |
| 2023-12-31 | -41.38% |
| 2022-12-31 | -54183.33% |
| 2021-12-31 | 41.28% |
| 2020-12-31 | -49842.86% |
| 2019-12-31 | 23.10% |
| 2018-12-31 | -5322.58% |
| 2017-12-31 | -166.83% |
| 2016-12-31 | -446.15% |
| 2015-12-31 | -12750.00% |